Recherche
-
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates
(PLoS ONE. vol. 13, n° 11, pp. e0207794, 2018-11-30)Article de revueLibre accès -
Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination
(International Journal of Infectious Diseases. vol. 74, pp. 83-96, 2018-09)Article de revueLibre accès -
Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions
(The Lancet HIV. vol. 6, n° 5, pp. e334-e340, 2019-05)Article de revueLibre accès -
Durable natural killer cell responses after heterologous two-dose Ebola vaccination
(NPJ vaccines. vol. 6, n° 1, pp. 19, 2021-01-29)Article de revueLibre accès -
Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo
(Cell Reports. vol. 42, n° 9, pp. 113101, 2023-09-26)Article de revueLibre accès -
A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial
(Journal of Virology, 2021-02-10)Article de revueLibre accès -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
(PLoS Medicine. vol. 19, n° 1, 2022-01-11)Article de revueLibre accès -
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)
(Trials. vol. 21, n° 1, pp. 846, 2020-10-13)Article de revueLibre accès -
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
(Clinical Microbiology and Infection. vol. 28, n° 7, pp. 1010-1016, 2022-07-01)Article de revueLibre accès -
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
(Frontiers in Immunology. vol. 10, 2019-04-24)Article de revueLibre accès